Company's Clean Tech Process to Transform CO2 Into a High Value Chemical Compound Used in the Production of Paper, Pharmaceuticals and Plastics
DALLAS, TX - May 19, 2008 - Carbon Sciences Inc. (CABN) has been reaffirmed ‘Speculative Buy’ by Beacon Equity Research Analyst Victor Sula, Ph.D.
The full report is available at http://www.BeaconEquity.com.
Anyone interested in receiving alerts regarding Carbon Sciences Inc. research should e-mail firstname.lastname@example.org with “CABN” in the subject line.
In the report, the analyst writes, “Since our initial report in November 2007, CABN has announced an exciting new application for the Company’s CO2 transformation technology. Targeting the multi-billion dollar PCC production market should greatly enhance CABN’s visibility and provide a source of near-term revenues. We regard CABN as a long-term investment play whose value lies in its innovative technology and huge potential market. Both of these long-term growth drivers remain intact in 2008.”
Other companies in the waste management industry include China BAK Battery Inc. (Nasdaq: CBAK - News) and Ballard Power Systems Inc. (Nasdaq: BLDP - News).
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of Carbon Sciences Inc. (CABN). Additionally the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research (“Beacon”) certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Principals of BER have purchased three hundred thousand shares of restricted stock from the company (CABN) at 15 cents per share; additionally, BER and its affiliates have been compensated five thousand dollars a month directly from the company for enrollment of CABN in its research program and other services. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. Any potential investors in CABN should note that our revenue analysis is not a company supplied revenue projection, but is strictly our opinion based on our independent analysis and research. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.